Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Hum Pathol. 2017 Apr 12;67:18–29. doi: 10.1016/j.humpath.2017.03.011

Table 1.

Clinico-pathological characteristics of Xp11 patients used in the study (N = 12, RN=radical nephrectomy; PN=partial nephrectomy).

Case Age/Sex Procedure Stage Size Nucleolar Grade Analysis Comments
1 10/F RN pT2NX, II 10.0 cm ISUP II Discovery set Necrotic
2 36/F RN pT2NX, II 7.8 cm ISUP IV Discovery set Sarcomatoid; recurred; SFPQ-TFE3
3 28/F PN pT1aNX, I 3.4 cm ISUP III Discovery set
4 34/F RN pT2bNO, II 12.5 cm ISUP II Discovery set
5 45/F RN pT3bNO (sinus), III 8.0 cm ISUP III Discovery set
6 36/F RN pT3NXM1 (bone), IV 4.7 cm ISUP II Discovery set Bone metastasis at diagnosis
7,8 14/M RN pT3aN0M0, III 3.7 cm ISUP III Discovery set ASPSCR1-TFE3; recurred locally x2
V1 62/M PN pTXNX, unknown 3.6 cm ISUP II Validation set Margin positive
V2 56/F PN pT1NX, I 4.5 cm ISUP III Validation set
V3 63/F PN pT1NX, I 3.5 cm ISUP II Validation set SFPQ-TFE3
V4 3/M RN pT1N1, III 4.0 cm ISUP II Validation set SFPQ-TFE3
V5 31/F RN pT1N0, I 5.0 cm ISUP II Validation set SFPQ-TFE3